JP2024525142A - Aavベクターカラム精製方法 - Google Patents

Aavベクターカラム精製方法 Download PDF

Info

Publication number
JP2024525142A
JP2024525142A JP2023576326A JP2023576326A JP2024525142A JP 2024525142 A JP2024525142 A JP 2024525142A JP 2023576326 A JP2023576326 A JP 2023576326A JP 2023576326 A JP2023576326 A JP 2023576326A JP 2024525142 A JP2024525142 A JP 2024525142A
Authority
JP
Japan
Prior art keywords
particles
column
raav
complete
chromatography medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525142A5 (cg-RX-API-DMAC7.html
Inventor
オンマル カナル
ヴィジェシュ クマール
ミ ジン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spark Therapeutics Inc
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of JP2024525142A publication Critical patent/JP2024525142A/ja
Publication of JP2024525142A5 publication Critical patent/JP2024525142A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
JP2023576326A 2021-06-11 2022-06-10 Aavベクターカラム精製方法 Pending JP2024525142A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US63/209,680 2021-06-11
US202263366094P 2022-06-09 2022-06-09
US63/366,094 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (2)

Publication Number Publication Date
JP2024525142A true JP2024525142A (ja) 2024-07-10
JP2024525142A5 JP2024525142A5 (cg-RX-API-DMAC7.html) 2025-06-17

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576326A Pending JP2024525142A (ja) 2021-06-11 2022-06-10 Aavベクターカラム精製方法

Country Status (13)

Country Link
US (1) US20240271159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351755A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525142A (cg-RX-API-DMAC7.html)
KR (1) KR20240021231A (cg-RX-API-DMAC7.html)
AU (1) AU2022289035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221540A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003646A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018191A2 (cg-RX-API-DMAC7.html)
IL (1) IL309070A (cg-RX-API-DMAC7.html)
MX (1) MX2023014809A (cg-RX-API-DMAC7.html)
PE (1) PE20240359A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022261663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
US20260085295A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. PARTITIONING ANION EXCHANGE CHROMATOGRAPHY FOR PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012521750A (ja) * 2009-03-27 2012-09-20 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ 肝硬変及び肝線維症の治療のための方法及び組成物
JP2018518164A (ja) * 2015-02-09 2018-07-12 インスティチュート ナショナル デ ラ サンテ エ デ ラ ルシェルシュ メディカル (インセルム) 多段階陰イオン交換クロマトグラフィーによる組換えアデノ随伴ウイルス粒子の精製
JP2020048586A (ja) * 2003-05-21 2020-04-02 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
JP2020526190A (ja) * 2017-06-30 2020-08-31 スパーク セラピューティクス インコーポレイテッドSpark Therapeutics, Inc. Aavベクターのカラム精製方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus
JP2025535118A (ja) * 2022-10-11 2025-10-22 メイラグティーエックス ユーケー アイアイ リミティド Aavカプシドの精製のためのクロマトグラフィー方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020048586A (ja) * 2003-05-21 2020-04-02 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
JP2012521750A (ja) * 2009-03-27 2012-09-20 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ 肝硬変及び肝線維症の治療のための方法及び組成物
JP2018518164A (ja) * 2015-02-09 2018-07-12 インスティチュート ナショナル デ ラ サンテ エ デ ラ ルシェルシュ メディカル (インセルム) 多段階陰イオン交換クロマトグラフィーによる組換えアデノ随伴ウイルス粒子の精製
JP2020526190A (ja) * 2017-06-30 2020-08-31 スパーク セラピューティクス インコーポレイテッドSpark Therapeutics, Inc. Aavベクターのカラム精製方法

Also Published As

Publication number Publication date
US20240271159A1 (en) 2024-08-15
PE20240359A1 (es) 2024-02-27
CA3221540A1 (en) 2022-12-15
BR112023025999A2 (pt) 2024-02-27
AU2022289035A1 (en) 2024-01-04
IL309070A (en) 2024-02-01
KR20240021231A (ko) 2024-02-16
EP4351755A1 (en) 2024-04-17
EP4351755A4 (en) 2025-04-23
WO2022261663A1 (en) 2022-12-15
CO2023018191A2 (es) 2024-01-25
CL2023003646A1 (es) 2024-10-25
CL2026000535A1 (es) 2026-06-12
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
JP7659523B2 (ja) カラムに基づく高度にスケーラブルなrAAVの製造プロセス
JP2025038906A (ja) Aavベクターのカラム精製方法
JP7153009B2 (ja) 高収率の組換えアデノ随伴ウイルス(rAAV)ベクターを生成するための、規模拡大可能な高回収率の方法、及びそれにより生成される組換えアデノ随伴ウイルス(rAAV)ベクター
US20240271159A1 (en) Aav vector column purification methods
JP2025535118A (ja) Aavカプシドの精製のためのクロマトグラフィー方法
CN117794629A (zh) Aav载体的柱纯化方法
RU2772876C2 (ru) Колоночные способы очистки вектора на основе aav
WO2025217029A1 (en) Compositions & methods for adeno-associated virus capsid variant purification
BR112019028299B1 (pt) Método para a purificação de partículas de vetores adenoassociados recombinantes (raav)
BR112018070256B1 (pt) Processo de fabricação de raav totalmente escalável à base de colunas
HK40003857B (en) Column-based fully scalable raav manufacturing process

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250609

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260601

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260601